BTG shares gain on solid interims while Interserve slumps for second day in a row
A look at the day's gainers and painers, including Vodafone, FirstGroup and Haydale Graphene
Company
Sareum Holdings PLC
LON:SAR
Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases, including psoriasis, and has completed Phase 1 clinical development.
239 stories · page 2 of 3
Investments and investor services
FTSE 100 flatlines at close as sterling gains on Brexit optimism
The UK blue-chip benchmark closed up 0.68 at 7,053, while the FTSE 250 added over 174 points at 18,985
Preliminary results from Sierra Oncology’s clinical trials of Sareum’s SRA737 compound due in H1 2019
US firm Sierra Oncology, which is the licence holder of SRA737, said in its quarterly update, it has made “substantial progress” with its two clinical development programmes for the compound
Archive
Proactive news snapshot: Immotion Group, NetScientific, AdEPT Technology …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Metal Tiger, Bacanora Lithium, Redx Pharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Cold weather in Nevada means Great Western Mining may have to suspend drilling until March
A look at some of the main news-driven risers and fallers in London on Friday ...
Sareum secures funding for drug programme
The company has raised £850,000 before expenses, which will be used to develop potential treatments for cancer and autoimmune diseases
FTSE 100 closes off lows but shoulders drop as US stocks plunge with tech disappointments
At the close, the UK blue-chip index was down 64.54 points, or 0.9% at 6,939.56, albeit bouncing off the hefty session low of 6,851.59 having spent all day heavily in the red
Archive
Proactive news snapshot: Greatland Gold, European Metals, Chesnara, BigDish...
A glance at some of the day's highlights from the Proactive Investors newswire
Sareum makes strong progress on cancer and autoimmune disease therapies
Sareum said it would continue talks with potential licence partners for its therapies under development
Archive
Proactive news snapshot: Amryt Pharma, Directa Plus, Live Company...
A glance at some of the day's highlights from the Proactive Investors newswire
Sareum selects potential anti-cancer molecule for further development
Sareum has now chosen two molecules from its TYK2 inhibitor programme for further development, one as a potential treatment for autoimmune disease and the other for certain types of cancer
Archive
Proactive news snapshot: IXICO, Mkango Resources, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Alumasc shares advance as it is 'well positioned' to outperform UK construction market
A look at some of the top risers and fallers in London on Tuesday
Sareum reports “strong progress” made with in-house and out-licensed drug programmes
Sierra Oncology is about to start the third trial of Sareum’s SRA737 Chk1 inhibitor, while internally, Sareum is making “good progress” with its TYK2 inhibitor programme
FTSE 100 stays in red at close as Brexit deal confidence wanes; trade fears persist
The UK bluechip index fell 25 points to 7,253 around 3.50pm
Archive
Proactive news snapshot: Savannah Resources, Rockfire Resources, OptiBiotix Health …
A glance at some of the day's highlights from the Proactive Investors newswire
UK Oil & Gas rallies after completing Portland reservoir test at Horse Hill
A look at some of the top risers and fallers in London on Monday
Sareum to further develop ‘potential best-in-class’ autoimmune disease treatment
Sareum thinks SDC-1801 is the most potent in the series of compounds and will now take it through pre-clinical development before advancing into human trials, which could begin as early as 2020
FTSE 100 ends in positive territory as Barnier now sees potential Brexit deal in weeks
The UK's index of leading shares added 1.6 points, or 0.02% , to finish at 7,279, while sterling was up 0.80% against the US dollar
Sareum Holdings investors receive update on progress of cancer drug
SRA737 is a checkpoint kinase-1 inhibitor, one of a new breed of treatments
Archive
Proactive news snapshot: Mirada, Touchstone Exploration, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Thor Mining, Echo Energy, Sound Energy, KEFI Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
£500mln wiped from Indivior’s value as generic version of its star asset launched in US
A look at some of the biggest risers and fallers in London on Friday afternoon...
FTSE 100 joins global rout as Trump's trade tactics spook markets
The UK's top share index shed over 131 points at 7,633, while mid-cap brother FTSE 250 was also lower
Investments and investor services
Strategic Minerals on a charge after agreeing battery materials deal with its largest customer
A look at the day's major movers, featuring Strategic Minerals, Avanti Communications, Transense, BlueRock Diamonds and Stratex
Sareum Holdings takes back promising cancer technology
The Aurora+FLT3 kinase inhibitors were being developed by Hebei Medical University Biomedical Engineering Center
Archive
Proactive news snapshot: Landore Resources, Vast Resources, Live Company …
A glance at some of the day's highlights from the Proactive Investors newswire
Sareum Holdings pleased as Sierra Oncology advances cancer drug trial
"We are very pleased with the progress that Sierra Oncology has made across its clinical trials and future plans with SRA737,” said Dr Tim Mitchell
Archive
Proactive news snapshot: Amryt Pharma, Bezant Resources, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
Proactive news snapshot: Redx Pharma, Tissue Regenix, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Tern shares spike up as holding company extends security capability for Microsoft’s internet of things platform
A look at some of the biggest risers and fallers in London on Tuesday
FTSE 100 extends gains in the final sessions
Stocks consolidated gains at the death with bid stock Shire the best performing blue-chip
Sareum Holdings shares spike ahead of US poster presentations
Currently, SRA737 is in phase I/II clinical trials as a single therapy to treat certain stress-driven cancers
Archive
Proactive news snapshot: PowerHouse Energy, Tertiary Minerals, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Hemogenyx, Futura Medical, Active Energy Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Minoan Group jumps as it signs exclusivity deal for sale of Travel & Leisure division
A look at some of the biggest risers and fallers in London on Tuesday
Sareum update reveals extent of progress made by co's licence partner
Sareum has partnered with Sierra Oncology to advance the company's Checkpoint kinase 1 inhibitor
Sareum Holdings: Sierra has ‘significantly expanded’ clinical development programme for its cancer drug
Sierra Oncology has announced ‘noteworthy progresses’ in the Dose Escalation Phase 1 portions for both of its ongoing Phase I/II clinical trials evaluating its potential best-in-class Chk1 inhibitor, SRA737
Archive
Proactive news snapshot: Strategic Minerals, Chariot Oil & Gas, dotdigital Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Sareum Holdings, Tlou Energy, Stobart Group
A glance at some of the day's highlights from the Proactive Investors newswire
Sareum Holdings: Pre-clinical data for new cancer combination to be presented to US peers
US firm Sierra Oncology, which has exclusively licensed Sareum's cancer candidate SRA737, will demonstrate that the molecule synergizes with niraparib
Investments and investor services
FTSE 100 closes in red, despite US market turnaround
In London, the FTSE 100 closed down around 29 points at 7,252
Archive
Proactive news snapshot: Horse Hill, Kromek Group, Base Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Fusion Antibodies up another 30% after posting a 35% leap on Monday's AIM debut
A look at some of the biggest risers and fallers in London on Tuesday
Sareum soars as it secures Chinese and Japanese patents for TYK2 inhibitors
European patents were granted back in 2014 and the cancer drug discovery firm expects the US and other major markets to follow suit “in due course”
FTSE 100 closes in positive territory but off session highs
The UK blue chip index closed around seven points higher at 7,544, below the day’s peak of 7,563
Sareum hails year of progress as it readies for another key period in its development
The AIM-listed group, whose focus is cancer and autoimmune diseases, licensed its SRA737 to US firm Sierra Oncology just over a year ago
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Sareum chairman hails “year of significant progress” and looks ahead to busy 2018
Chairman Stephen Parker will tell investors at today’s AGM that Sareum has enjoyed a “transformational” year
Archive
Proactive news spotlight - Xtract Resources, Directa Plus, IronRidge Resources, Avation, BOS GLOBAL, appScatter, Akers Biosciences, Belvoir Lettings
It was another busy day for London's junior miners, drug developers and technology groups.
Sareum announces £700,000 fundraising to support drug development programmes
The company placed 100 mln new ordinary shares of 0.025p each at a price of 0.7p per share
Archive
Proactive news snapshot: Wolf Minerals , Sareum Holdings, ReNeuron Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Metminco rallies on quarterly update, Pantheon Resources shares fall on drilling difficulties
A look at some of the biggest risers and fallers in London today
Latest preclinical data for Sareum’s cancer fighting Chk1 inhibitor impresses
"The data generated from these experiments are consistent with recent findings from our research and demonstrate that a potent and selective Chk1 inhibitor such as SRA737 can effectively synergize with sub-therapeutic doses of gemcitabine t
FTSE 100 closes a shade higher as pound strengthens ahead of rate decision
Around 4pm, the UK blue chip index rose 2 points to 7,490
Archive
Proactive news snapshot: Jersey Oil and Gas, Landore Resources, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot - Sphere Medical Holding, Empresaria Group, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
Hostelworld shares jump as it swings to first half profit despite impact of terror attacks on tourism
A look at some of the top risers and fallers in London today
Full-year profits at Sareum to be better-than-expected
It was only a brief pre-close trading update, but there will be enough in it to please Sareum investors
FTSE 100 rises sharply despite Provident Financial nightmare
The FTSE 100 rose 63 points to 7,382 and the pound has slipped amid Brexit fears
Archive
Proactive end of day round-up: Amur Minerals; 88 Energy; Mosman Oil & Gas ..
A glance at some of the the small cap news on the Proactive newswire today
Fusionex shares rebound amid backlash from Standard Life on plans to cancel AIM listing
A look at the biggest risers and fallers in London today
Sareum Holdings represents UK at cancer cluster conference
Sareum is one of three companies from the UK "Golden Triangle" biotechnology cluster.
Investments and investor services
FTSE 100 ends higher on day Brexit negotiations begin
The FTSE 100 closed 60 points up at 7,523 as the government begins Brexit negotiations.
Archive
Sierra Oncology encouraged by early progress on SRA737 clinical trials
Checkpoint Kinase 1 (Chk1) is Sareum’s most advanced program; it has been licensed to Sierra Oncology.
Archive
Proactive news round-up: Eurasia Mining, Gemfields, OPG Power Ventures...
Some of the small cap stories on the Proactive newswire today
Styles&Wood Group heads higher on chipper outlook
Some of the main risers and fallers in London at 3.40pm
Sareum welcomes more patent protection for anti-cancer candidate
Tim Mitchell, Sareum’s chief executive, said: "SRA737 is a valuable asset to Sareum through its licence to Sierra Oncology. "
FTSE 100 closes lower as election worries dent sentiment
The FTSE 100 closed down 6.56, or 0.09% to 7,519...
Archive
Sierra Oncology to present data on trials using Sareum's Chk1 inhibitor
Sierra holds exclusive rights to SRA737, having licensed the programme from Sareum's co-investment partner, the CRT Pioneer Fund
Sareum to present at leading European biopharma conference this week
Chief executive Tim Mitchell will be giving two presentations today and tomorrow at BioTrinity in Hammersmith, London
EQTEC steps on gas as parent converts loan
Some of the largest rises and falls in London at 3.15pm: EQTEC, Goldplat, Feedback
Sareum posts maiden profit after cancer drug payment
The Sierra licence triggered an upfront payment to Sareum
Investments and investor services
FTSE closes flat as Unilever holds market back
The FTSE 100 ended flat on Monday as Unilever shares sank in the wake of Kraft Heinz saying it had abandoned its proposed merger which would have been one of the biggest in corporate history
Archive
Proactive news round-up: Orogen Gold, Braveheart Investment, Concepta ...
A glance at some of the stories on the Proactive newswire today
Sareum boosted by second cancer milestone payment
Sareum is entitled to 27.5% of all payments arising from the Chk1 licence agreement
Risers and fallers: Next, Sirius Minerals, Victoria Oil & Gas
Shares in Victoria Oil & Gas were up after it spudded two development wells at its Logbaba gas field in Cameroon
“Strong” 2016 leaves Sareum in good shape for growth
The past year has seen the company go from strength to strength, culminating in the licensing of its most advanced programme
Small Cap highlights: Sareum leads Monday’s stand-out small cap biotech stocks
Sareum, Faron, WideCells, Abzena and Ergomed were among Monday's small cap highlights